{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:15:00Z","timestamp":1765545300059},"reference-count":36,"publisher":"Wiley","issue":"1-2","license":[{"start":{"date-parts":[[2005,2,24]],"date-time":"2005-02-24T00:00:00Z","timestamp":1109203200000},"content-version":"vor","delay-in-days":54,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Pharma Physio"],"published-print":{"date-parts":[[2005,1]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>1.\u2002The aim of the present study was to investigate the activity of anterior hypothalamic \u03b2\u2010adrenoceptors and angiotensin (Ang) II receptors on blood pressure in normotensive rats and aortic\u2010coarctated (ACo) animals at a chronic stage of hypertension. A possible interaction between \u03b2\u2010adrenoceptors and AngII pressor activity was also investigated.<\/jats:p><jats:p>2.\u2002Injection of isoproterenol (0.1\u201310\u00a0nmol) in the anterior hypothalamic area induced a dose\u2010dependent decrease in mean arterial pressure (MAP) in sham\u2010operated (SO), but not in ACo, animals. Isoproterenol (1\u00a0nmol) reduced blood pressure in SO rats (\u0394MAP \u221210.1\u00a0\u00b1\u00a01.4\u00a0mmHg; <jats:italic>n<\/jats:italic>\u00a0=\u00a010) but not in ACo animals (\u0394MAP \u22120.9\u00a0\u00b1\u00a01.6\u00a0mmHg; <jats:italic>n<\/jats:italic>\u00a0=\u00a010; <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.05 <jats:italic>vs<\/jats:italic> SO rats). Whereas previous administration of atenolol (40\u00a0nmol) enhanced the cardiovascular effect of isoproterenol (1\u00a0nmol) in ACo rats but not in SO animals, propranolol (40\u00a0nmol) prevented the hypotensive action of isoproterenol in both experimental groups. Intrahypothalamic administration of clenbuterol decreased MAP in a dose\u2010dependent manner; however, the depressor response to clenbuterol (10\u00a0nmol) was greater in ACo rats than in SO rats (\u0394MAP \u221226.8\u00a0\u00b1\u00a03.2 <jats:italic>vs<\/jats:italic>\u221214.4\u00a0\u00b1\u00a02.4\u00a0mmHg, respectively; <jats:italic>n<\/jats:italic>\u00a0=\u00a05 for both; <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.05). When AngII (50\u00a0ng) was injected into the anterior hypothalamic area, a greater pressor response was observed in ACo rats than in SO rats (\u0394MAP 19.6\u00a0\u00b1\u00a01.1 <jats:italic>vs<\/jats:italic> 11.3\u00a0\u00b1\u00a00.6\u00a0mmHg, respectively; <jats:italic>n<\/jats:italic>\u00a0=\u00a05 for both; <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.05). Atenolol (40\u00a0nmol) pretreatment partially and significantly prevented the pressor response to AngII in ACo rats, but not in SO rats.<\/jats:p><jats:p>3.\u2002In conclusion, these results provide pharmacological evidence for the existence of a \u03b2<jats:sub>1<\/jats:sub>\u2010adrenoceptor\u2010mediated pressor mechanism in the anterior hypothalamic area of ACo rats that is absent in SO rats. The enhanced depressor \u03b2<jats:sub>2<\/jats:sub>\u2010adrenoceptor activity observed in chronic ACo rats could be a compensatory adjustment to pressor \u03b2<jats:sub>1<\/jats:sub>\u2010adrenoceptor activity. Conversely, pressor overactivity of AngII was observed in the anterior hypothalamic area of ACo rats at a chronic hypertensive stage; this enhancement could be explained, at least in part, by the pressor \u03b2<jats:sub>1<\/jats:sub>\u2010adrenoceptor activity.<\/jats:p>","DOI":"10.1111\/j.1440-1681.2005.04150.x","type":"journal-article","created":{"date-parts":[[2005,2,24]],"date-time":"2005-02-24T18:29:17Z","timestamp":1109269757000},"page":"30-34","source":"Crossref","is-referenced-by-count":6,"title":["Anterior hypothalamic \u03b2\u2010adrenoceptors in chronic aortic\u2010coarctated hypertensive rats: An interaction with central angiotensin II receptors"],"prefix":"10.1111","volume":"32","author":[{"given":"Christian","family":"H\u00f6cht","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier AW","family":"Opezzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariela M","family":"Gironacci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos A","family":"Taira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,2,24]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.2001.81.4.1599"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199816121-00002"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199108000-00001"},{"key":"e_1_2_6_5_2","first-page":"S159","article-title":"Sympatho\u2010excitatory neurons of the rostral ventrolateral medulla are oxygen sensors and essential elements in the tonic and reflex control of the system and cerebral circulation","volume":"12","author":"Reis DJ","year":"1994","journal-title":"J. Hypertens."},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.3109\/10641967809068609"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1983.tb10006.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(86)90125-1"},{"key":"e_1_2_6_9_2","first-page":"111","article-title":"Central antihypertensive activity of propranolol","volume":"243","author":"Zawoiski EJ","year":"1980","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"e_1_2_6_10_2","volume-title":"Atlas of Neuroactive Substance and Their Receptors in the Rat","author":"Tohyama M","year":"1998"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.19.5.475"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199508000-00009"},{"key":"e_1_2_6_13_2","first-page":"H349","article-title":"Central nervous system action of angiotensin during onset of renal hypertension in awake rats","volume":"247","author":"Faber JE","year":"1984","journal-title":"Am. J. Physiol."},{"key":"e_1_2_6_14_2","first-page":"H261","article-title":"Central renin\u2013angiotensin system and the pathogenesis of DOCA\u2010salt hypertension in rats","volume":"251","author":"Itaya Y","year":"1986","journal-title":"Am. J. Physiol."},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-0115(97)11050-3"},{"key":"e_1_2_6_16_2","volume-title":"Current Concepts: Tissue Renin\u2013Angiotensin System as Local Regulators in Reproductive and Endocrine Organs","author":"Raizada MK","year":"1994"},{"key":"e_1_2_6_17_2","first-page":"379","volume-title":"Cellular and Molecular Biology of the Renin\u2013Angiotensin System","author":"Sumners C","year":"1993"},{"key":"e_1_2_6_18_2","first-page":"553","article-title":"Role of the renin\u2013angiotensin system in hypertension after coarctation of the aorta","volume":"4","author":"Bailie MD","year":"1984","journal-title":"J. Lab. Clin. Med."},{"key":"e_1_2_6_19_2","first-page":"H1480","article-title":"Acute aortic coarctation hypertension: Role of vasopressin and angiotensin II","volume":"7","author":"Salgado HC","year":"1989","journal-title":"Am. J. Physiol."},{"key":"e_1_2_6_20_2","first-page":"152","article-title":"Mechanical and neuro\u2010humoral factors in acute aortic coarctation hypertension","volume":"36","author":"Salgado HC","year":"1992","journal-title":"Agents Actions Suppl."},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.23.1_Suppl.I78"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0100-879X1997001000018"},{"issue":"2","key":"e_1_2_6_23_2","first-page":"159","article-title":"Baroreceptor reflex control of heart rate during development of coarctation hypertension","volume":"2","author":"Michelini LC","year":"1992","journal-title":"Hypertension"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2003.07.003"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1043-6618(03)00126-9"},{"key":"e_1_2_6_26_2","volume-title":"Guide for the Care and Use of Laboratory Animals. A Report of the Institute of Laboratory Animal Resource Committee on the Care and Use of Laboratory Animals.","author":"National Research Council.","year":"1985"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1139\/y68-137"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.283.5400.401"},{"key":"e_1_2_6_29_2","volume-title":"Computational Handbook of Statistics","author":"Brunning JL","year":"1977"},{"key":"e_1_2_6_30_2","first-page":"382","volume-title":"Neglected Factors in Pharmacology and Neuroscience Research","author":"Claassen V","year":"1994"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0361-9230(00)00266-5"},{"key":"e_1_2_6_32_2","first-page":"759","article-title":"A stereoselective central hypotensive action of atenolol","volume":"250","author":"Pearson AA","year":"1986","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(92)90377-L"},{"key":"e_1_2_6_34_2","first-page":"R257","article-title":"Central injection of angiotensin II alters catecholamine activity in rat brain","volume":"244","author":"Sumners C","year":"1983","journal-title":"Am. J. Physiol."},{"key":"e_1_2_6_35_2","first-page":"102","article-title":"Role of anteroventral third ventricle (AV3V) region in experimental hypertension","volume":"43","author":"Brody MJ","year":"1978","journal-title":"Circ. Res."},{"key":"e_1_2_6_36_2","first-page":"R106","article-title":"Separation of drinking and pressor responses to central angiotensin by monoamines","volume":"240","author":"Camacho A","year":"1981","journal-title":"Am. J. Physiol."},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0149-7634(94)90034-5"}],"container-title":["Clinical and Experimental Pharmacology and Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1681.2005.04150.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1681.2005.04150.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T10:27:14Z","timestamp":1693477634000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1681.2005.04150.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":36,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["10.1111\/j.1440-1681.2005.04150.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1681.2005.04150.x","archive":["Portico"],"relation":{},"ISSN":["0305-1870","1440-1681"],"issn-type":[{"value":"0305-1870","type":"print"},{"value":"1440-1681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}